Articles, guides, and regulatory updates from our community.
A 2026 rat study suggests BPC 157 may reduce oxidative stress and muscle damage from ischemia-reperfusion injury. Learn what the research found.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Read the findings and what they mean for research.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's development barriers, formulation challenges, and why human clinical data remains critically limited.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's biopharmaceutical challenges, pharmacokinetic gaps, and the barriers standing between preclinical promise and human trials.
By Peptide Association Research Team
A 2026 rat study found BPC 157 may reduce oxidative stress and apoptosis in lower limb ischemia-reperfusion injury. Learn what the research suggests.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines why BPC-157 lacks approved formulations, validated dosing, and completed Phase II trials despite 30+ years of preclinical data.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may protect against ischemia-reperfusion injury by reducing oxidative stress, inflammation, and cell death. Learn what the research shows.
By Peptide Association Research Team
A 2026 review in JBJS Reviews examines the evidence, safety, and antidoping implications of injectable peptides used in sports medicine and orthopaedics.
By Peptide Association Research Team
A 2026 structured review examines injectable peptides for musculoskeletal recovery. Learn what the evidence, safety data, and antidoping rules mean for athletes.
By Peptide Association Research Team
A 2026 study found BPC 157 may relax human arterial tissue via nitric oxide pathways. Learn what the research suggests and what patients should know.
By Peptide Association Research Team
A 2026 study suggests BPC 157 may relax human arterial tissue via nitric oxide signaling. Learn what the research found and what it means for vascular health.
By Peptide Association Research Team
A 2026 study found BPC 157 may promote vasorelaxation in human arterial tissue via nitric oxide pathways. Learn what the research suggests.
By Peptide Association Research Team
New research examines safety profiles of approved and unapproved peptide therapies for sports medicine, revealing gaps in human safety data for popular compounds.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team
Recent study reveals tirzepatide achieved 22.7% weight loss at 52 weeks using telehealth protocol. Learn clinical implications for peptide therapy providers.
By Peptide Association Research Team
New research on SS-31 peptide reveals neuroprotective mechanisms in stroke models. Study findings on mitochondrial peptide therapy for brain health.
By Peptide Association Research Team
New research on retatrutide, a triple-agonist peptide therapy, demonstrates significant benefits for type 2 diabetes and obesity management in clinical studies.
By Peptide Association Research Team
New study reveals safety concerns about peptides used for tendon repair and athletic enhancement. Critical insights for healthcare providers and patients.
By Peptide Association Research Team
Breakthrough research reveals enhanced bioavailability of peptide minerals through innovative encapsulation technology. Learn what this means for therapy.
By Peptide Association Research Team
Breakthrough study reveals SS-31 mitochondrial peptide therapy combined with NMN shows promise for sarcopenia treatment. Learn about NAD peptide therapy advances.
By Peptide Association Research Team
Groundbreaking study reveals how spray-drying optimization improves peptide suspension stability for therapeutic applications including tendon repair.
By Peptide Association Research Team
New research reveals stable peptide formulation methods for glatiramer acetate nanoparticles, advancing peptide therapy manufacturing and storage solutions.
By Peptide Association Research Team
New research examines cost-effectiveness of diabetes medications. Learn about peptide therapy regulation and safety considerations for healthcare providers.
By Peptide Association Research Team
Breakthrough study reveals self-assembling peptide hydrogels enhance nerve regeneration when combined with stem cells. Learn about this promising research.
By Peptide Association Research Team
Groundbreaking research reveals next-generation GLP-1 peptide therapies targeting multiple receptors for enhanced diabetes and obesity treatment outcomes.
By Peptide Association Research Team
New research reveals how MAPK p38α inhibition overcomes FPR1 mutations affecting immune surveillance. Learn about peptide therapy implications.
By Peptide Association Research Team
New FDA study reveals higher adverse events in compounded GLP-1 peptides vs commercial versions. Important safety insights for peptide therapy providers.
By Peptide Association Research Team
New study shows chitosan-polylysine particles create effective sustained-release system. Learn implications for peptide delivery and therapeutic applications.
By Peptide Association Research Team
Latest 2026 research reveals BPC-157's potential for joint repair, tendon healing, and pain management. Study findings, dosage insights, and clinical implications.
By Peptide Association Research Team
Latest 2026 study reveals BPC 157's dual role in preventing hemorrhage and thrombosis. Learn about dosage implications and clinical significance for providers.
By Peptide Association Research Team
How peptides like BPC-157, larazotide, and KPV are being studied for gastrointestinal conditions — from inflammatory bowel disease to intestinal barrier repair.
By Peptide Association Editorial Team
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.
By Peptide Association Editorial Team
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team